Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-009116

EVP, R&D & Chief Scientific Of sold 13,975 shares at $38.55 ($538,736)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2019-02-11 Sale −13,975 $38.55 $538,736 272,718 D
Open-market sales · 13,975 sh · avg $38.55 · $538,736
Loading xslF345X03/doc4.xml…